MiR-429 is a member of the miR-200 family (miR-141, miR-200a, miR-200b, and miR-200c) and was reported to target the ERG gene in prostate cancer and promote angiogenesis in hepatocellular carcinoma [74]. Here, ERG is linked to prostate cancer.